Skip to content
  • About
  • Contact
  • Contribute
  • Book
  • Careers
  • Podcast
  • Recommended
  • Speaking
  • All
  • Physician
  • Practice
  • Policy
  • Finance
  • Conditions
  • .edu
  • Patient
  • Meds
  • Tech
  • Social
  • Video
    • All
    • Physician
    • Practice
    • Policy
    • Finance
    • Conditions
    • .edu
    • Patient
    • Meds
    • Tech
    • Social
    • Video
    • About
    • Contact
    • Contribute
    • Book
    • Careers
    • Podcast
    • Recommended
    • Speaking

Upholding the principles of informed consent in the fight against vaccine hesitancy

Iris Kulbatski, PhD
Conditions
January 14, 2021
404 Shares
Share
Tweet
Share

Experts have taken to social media to quell misinformation and address common concerns about Pfizer’s messenger RNA (mRNA) COVID-19 vaccine, performing an important public service in support of robust vaccine uptake. However, some scientific information is being oversimplified to the point that it is misleading. The public’s decision to take a vaccine whose long-term risks are unclear should be a well-informed one. Clear communication is crucial to the process of informed consent and for building public trust in the fight against vaccine hesitancy.

Take, for example, a video posted to Twitter by a bioengineer working on COVID vaccines. Presented as “Three facts about the long-term effects of the COVID vaccine,” the researcher makes a case for the long-term safety of RNA COVID-19 vaccines. mRNA carries the instructions for making proteins and is a normal part of protein production in the body. mRNA COVID-19 vaccines deliver synthetic mRNA into the body, which tells cells to make one of the COVID-19 surface proteins – which they do. The immune system then produces an immune response to this protein, preparing the body to fight the actual virus in the future.

Fact No. 3 in the Twitter video suggests that because the RNA drug Onpattro received U.S. Food and Drug Administration (FDA) approval in 2018, has a similar formulation to RNA COVID-19 vaccines and is safe long-term, RNA COVID-19 vaccines are also safe long-term.

Indeed, Onpattro – used to treat a fatal rare neurological disorder by interfering with the RNA instructions for making an abnormal protein – and Pfizer’s vaccine are similar in that they are both “RNA in a lipid nanoparticle” that affect protein production in the body.

However, the safety comparison between Onpattro and mRNA COVID-19 vaccines is oversimplified and misleading. It implies that we can rely on the Onpattro clinical trials for assurance that all “RNA in a lipid nanoparticle” technology is safe. But the long-term safety of one type of RNA technology does not mean that another is equally as safe. If that were the case, RNA vaccines would not require independent testing to the extent that they do.

The conditions of different clinical trials can vary widely, especially when the underlying medical disorder is different. Such variations include study design, criteria for selecting research participants, and outcome measures for safety and efficacy. Here’s one example of how the Onpattro trials differ from Pfizer’s COVID-19 vaccine trials: Participants in Onpattro’s trials were pre-medicated with steroids and antihistamines to minimize infusion-related reactions to treatment. Pfizer’s clinical trial participants were not because suppressing an immune reaction in a vaccine trial goes against the principles of the therapy. In fact, the exclusion criteria for Pfizer’s trial makes anyone taking steroids or other immune suppression therapy ineligible.

This difference alone is enough to question the comparison between Onpattro’s safety and RNA vaccine safety. Pre-medication with steroids and antihistamines before receiving an “RNA in a lipid nanoparticle” therapy may improve the treatment’s safety profile. In this respect, directly comparing the safety profiles of Onpattro and RNA vaccines is unreliable.

While the concept of RNA manipulation for treating or preventing disease is not new, the FDA has never before approved a commercial vaccine made from RNA. Shorter-term safety has been shown for the Pfizer vaccine but we do not yet have information about possible longer-term side effects, because we have not yet reached long-term milestones for safety testing. The estimated completion date for the current Pfizer clinical trial is January 27, 2023. Even so, it does not include specific outcome measures for safety at the 1- or 2-year time points. We cannot know about long-term effects until we reach the long-term in clinical trials designed to gather specific safety data. Inferring long-term safety from Onpattro’s clinical trials is just that – inference, not evidence.

Moreover, there remain many outstanding questions about these vaccines that require further research. For example, Canada’s National Advisory Committee on Immunization outlines a list of research priorities for COVID-19 vaccines, including those related to efficacy, safety and immunogenicity. This is not to say that people should necessarily wait to be vaccinated until long-term safety is known, but rather that scientific information be communicated fully and clearly so that the public has an opportunity to adequately weigh the risks and benefits of their decision.

Fighting misinformation and vaccine hesitancy requires a balanced and unbiased presentation of facts to uphold informed consent principles. In our efforts to present science in an easily understandable way, let’s remain mindful of the pendulum of misinformation and prevent it from swinging too far in the opposite direction.

Iris Kulbatski is a science writer. 

Image credit: Shutterstock.com

Prev

A crisis of physician intra-professional respect [PODCAST]

January 13, 2021 Kevin 0
…
Next

Why some patients refuse care

January 14, 2021 Kevin 0
…

Tagged as: COVID, Infectious Disease

Post navigation

< Previous Post
A crisis of physician intra-professional respect [PODCAST]
Next Post >
Why some patients refuse care

More by Iris Kulbatski, PhD

  • Medical errors? Sorry, not sorry.

    Iris Kulbatski, PhD
  • “We are not that great.” Gain-of-function research highlights our hubris

    Iris Kulbatski, PhD
  • The culture of silence in Canada’s medical institutions is in desperate need of reform

    Iris Kulbatski, PhD

Related Posts

  • Rethinking consent in the age of Facebook and Cambridge Analytica

    Peter F. Nichol, MD, PhD
  • The dismantling of informed consent is a disaster

    David Penner
  • Physicians fight from the social media frontlines

    Neha Pidatala, MD
  • The basics of the MMR vaccine from a pediatrician

    Roy Benaroch, MD
  • No, the HPV vaccine isn’t optional

    Chad Hayes, MD
  • A view from Canada: Defending vaccine passports

    Bryan Thomas and Colleen M. Flood

More in Conditions

  • The surprising medical mystery of a “good” Hitler: How a rescued kitten revealed a rare movement disorder

    Teresella Gondolo, MD
  • The power of coaching for physicians: transforming thoughts, changing lives

    Kim Downey, PT
  • Unlocking the secrets of cancer conferences: an end-of-life counselor’s journey among pharmaceutical giants

    Althea Halchuck, EJD
  • An obstetrician-gynecologist reveals the truth about reproductive planning and how to navigate society’s expectations

    Yuliya Malayev, DO, MPH
  • Nose-brain connection: The surprising link between allergies and mental health revealed

    Kara Wada, MD
  • Is the rise in mental illness due to greater awareness or a true increase in incidence?

    Zahid Awan, MD
  • Most Popular

  • Past Week

    • A patient’s perspective on the diminishing relationship between doctors and patients

      Michele Luckenbaugh | Conditions
    • Unmasking wage disparity in health care: the truth behind the Elmhurst Hospital physician strike

      Kevin Pho, MD | KevinMD
    • Why affirmative action is crucial for health equity and social justice in medicine

      Katrina Gipson, MD, MPH | Policy
    • Emulating Michael Jordan’s winning mindset: a path to success for health care professionals and entrepreneurs

      Harvey Castro, MD, MBA | Physician
    • How electronic health records preserve patients’ legacies in the words of oncologists

      Marc Braunstein, MD, PhD | Physician
    • Unmasking the brutal reality of gun violence in America: a call to action for unity and meaningful change

      Osmund Agbo, MD | Policy
  • Past 6 Months

    • The growing threat to transgender health care: implications for patients, providers, and trainees

      Carson Hartlage | Policy
    • It’s time to replace the 0 to 10 pain intensity scale with a better measure

      Mark Sullivan, MD and Jane Ballantyne, MD | Conditions
    • Breaking point: the 5 reasons American doctors are dreaming of walking away from medicine

      Amol Shrikhande, MD | Physician
    • “Is your surgeon really skilled? The hidden threat to public safety in medicine.

      Gene Uzawa Dorio, MD | Physician
    • Revolutionize your practice: the value-based care model that reduces physician burnout

      Chandravadan Patel, MD | Physician
    • Breaking the cycle of racism in health care: a call for anti-racist action

      Tomi Mitchell, MD | Policy
  • Recent Posts

    • Uncovering the truth about racial health inequities in America: a book review

      John Paul Mikhaiel, MD | Policy
    • Why electronic health records are failing patients: the dark side of copy and paste [PODCAST]

      The Podcast by KevinMD | Podcast
    • The hidden factor in physician burnout: How the climate crisis is contributing to the erosion of well-being

      Elizabeth Cerceo, MD | Physician
    • The surprising medical mystery of a “good” Hitler: How a rescued kitten revealed a rare movement disorder

      Teresella Gondolo, MD | Conditions
    • The power of coaching for physicians: transforming thoughts, changing lives

      Kim Downey, PT | Conditions
    • Why doctors aren’t to blame for the U.S. opioid crisis [PODCAST]

      The Podcast by KevinMD | Podcast

Subscribe to KevinMD and never miss a story!

Get free updates delivered free to your inbox.


Find jobs at
Careers by KevinMD.com

Search thousands of physician, PA, NP, and CRNA jobs now.

Learn more

View 1 Comments >

Founded in 2004 by Kevin Pho, MD, KevinMD.com is the web’s leading platform where physicians, advanced practitioners, nurses, medical students, and patients share their insight and tell their stories.

Social

  • Like on Facebook
  • Follow on Twitter
  • Connect on Linkedin
  • Subscribe on Youtube
  • Instagram

CME Spotlights

From MedPage Today

Latest News

  • 'Medically Relevant to Saving the Life of Your Patient': What We Heard This Week
  • Want to Solve the Nurse Shortage?
  • Why Are Female Doctors Sued Nearly Half as Often as Male Doctors?
  • What Drug Did FDA Just Approve for COVID?
  • PET Scan for Alzheimer's Dx; Predicting Colon Cancer Survival

Meeting Coverage

  • No Access to Routine Healthcare Biggest Barrier to HPV Vaccination
  • Trial Results Spark Talk of Curing More Metastatic Cervical Cancers
  • Cross-Border Collaboration Improves Survival in Pediatric Leukemia Patients
  • Monoclonal Antibody Reduced Need For Transfusions in Low-Risk MDS
  • Less-Invasive Surgery for Pancreatic Cancer Proves Safe, Effective
  • Most Popular

  • Past Week

    • A patient’s perspective on the diminishing relationship between doctors and patients

      Michele Luckenbaugh | Conditions
    • Unmasking wage disparity in health care: the truth behind the Elmhurst Hospital physician strike

      Kevin Pho, MD | KevinMD
    • Why affirmative action is crucial for health equity and social justice in medicine

      Katrina Gipson, MD, MPH | Policy
    • Emulating Michael Jordan’s winning mindset: a path to success for health care professionals and entrepreneurs

      Harvey Castro, MD, MBA | Physician
    • How electronic health records preserve patients’ legacies in the words of oncologists

      Marc Braunstein, MD, PhD | Physician
    • Unmasking the brutal reality of gun violence in America: a call to action for unity and meaningful change

      Osmund Agbo, MD | Policy
  • Past 6 Months

    • The growing threat to transgender health care: implications for patients, providers, and trainees

      Carson Hartlage | Policy
    • It’s time to replace the 0 to 10 pain intensity scale with a better measure

      Mark Sullivan, MD and Jane Ballantyne, MD | Conditions
    • Breaking point: the 5 reasons American doctors are dreaming of walking away from medicine

      Amol Shrikhande, MD | Physician
    • “Is your surgeon really skilled? The hidden threat to public safety in medicine.

      Gene Uzawa Dorio, MD | Physician
    • Revolutionize your practice: the value-based care model that reduces physician burnout

      Chandravadan Patel, MD | Physician
    • Breaking the cycle of racism in health care: a call for anti-racist action

      Tomi Mitchell, MD | Policy
  • Recent Posts

    • Uncovering the truth about racial health inequities in America: a book review

      John Paul Mikhaiel, MD | Policy
    • Why electronic health records are failing patients: the dark side of copy and paste [PODCAST]

      The Podcast by KevinMD | Podcast
    • The hidden factor in physician burnout: How the climate crisis is contributing to the erosion of well-being

      Elizabeth Cerceo, MD | Physician
    • The surprising medical mystery of a “good” Hitler: How a rescued kitten revealed a rare movement disorder

      Teresella Gondolo, MD | Conditions
    • The power of coaching for physicians: transforming thoughts, changing lives

      Kim Downey, PT | Conditions
    • Why doctors aren’t to blame for the U.S. opioid crisis [PODCAST]

      The Podcast by KevinMD | Podcast

MedPage Today Professional

An Everyday Health Property Medpage Today
  • Terms of Use | Disclaimer
  • Privacy Policy
  • DMCA Policy
All Content © KevinMD, LLC
Site by Outthink Group

Upholding the principles of informed consent in the fight against vaccine hesitancy
1 comments

Comments are moderated before they are published. Please read the comment policy.

Loading Comments...